BioNano Genomics, Inc. (BNGO) Posts Q3 Revenue of $2.8M

BioNano Genomics, Inc. (NASDAQ: BNGO) reported Q3 revenue of $2.8 million versus the consensus estimate of $2.45 million.

For earnings history and earnings-related data on BioNano Genomics, Inc. (BNGO) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Nucor projects Q3 2026 earnings above prior year, below estimates
• Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia